|
|
Office Locations:
|
47 Thorndike Street, Suite B1-1
Cambridge, MA 02141
Phone: 617-252-4343
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Founded 1985, HealthCare Ventures (HCV) is a venture capital firm specializing in life science industry investing. The firm's target sectors include: target-focused cancer, infectious disease, cardiovascular disease, central nervous system disorders, immunomodulation and immunotherapy, novel manufacturing technologies, and novel lab scale instruments and reagents. The firm has raised over $1.6 billion in capital and has managed nine funds over the past 35 years. The fund's typical initial investments range between $1 million to $20 million in the form of equity or debt convertible to equity. HCV has invested in a total of 107 companies, 68 of which were start-ups.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
